0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV252.11%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier54DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Alpha Tau Medical Stock Discussion
NEWS
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US)$
- Co on Sunday Announced Results of Relapsed Pediatric Low-Grade Glioma Show 64% Overall Response Rate. recently added. Looking for more above $18.
$Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares(DRIP.US)$